November 2023. Examines commercial plans' management of high and ultra high-cost therapies, discusses financing and contracting mechanisms, and evaluates best-in-class manufacturer support and commercial MCO needs going forward.
2023 Research
October 2023. Reviews issues in specialty pharmacy dispensing and distribution of rare disease and gene therapy medications. Examines network considerations, specialty pharmacy capabilities, contracting approaches, and best-in-class manufacturer engagement/support.
August 2023. Examines payer and provider adoption and the contracting landscape for biosimilars and brand originators in inflammation & immunology, cancer supportive therapies, and oncology.
July 2023. Reviews contract prevalence with key commercial payer segments, most common contracting approaches, and rebate/discount amounts offered across 40+ therapeutic areas spanning traditional, specialty and oncology.
-
A number of innovative rare disease and gene therapy treatments have entered the market, requiring novel utilization management, financing, and contracting approaches. HIRC’s report, Rare Disease...
-
Specialty pharmacies are developing robust and unique capabilities to support the upcoming pipeline of rare disease & gene therapies, and can serve as strong partners in patient access and...
-
Biosimilars have changed the competitive environment across key therapeutic areas such as inflammation & immunology, cancer supportive therapies, and oncology. HIRC's report, Biosimilars:...
-
Pharmaceutical manufacturer contracting is a key element of account engagement to enhance and/or maintain market access; however, the contracting landscape can vary greatly upon on many...
HIRC Special Report Series
Special Report Topics
Special report topics vary annually based upon the current health care environment. Research directors and consultants select topics or insights that are highly relevant, of high interest, and/or are critical for manufacturers to be aware of. Special reports often draw upon data across HIRC services, allowing readers to glean insights into high level topics across varying market segments, channels, and/or therapeutic areas.
